首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata

【2h】

Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata

机译：克服耐药性障碍：瑞沙芬净（CD101）对白色念珠菌和光滑念珠菌的药代动力学-药效学目标分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Antimicrobial Agents and Chemotherapy
作者
Justin C. Bader; Elizabeth A. Lakota; Shawn Flanagan; Voon Ong; Taylor Sandison; Christopher M. Rubino; Sujata M. Bhavnani; Paul G. Ambrose;
展开▼
作者单位

展开▼
年(卷),期 2018(62),6
年度 2018
页码 e02614-17
总页数 9
原文格式 PDF
正文语种
中图分类药学;微生物学;
关键词

相似文献

外文文献
专利

1. Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata [J] . Bader Justin C., Lakota Elizabeth A., Flanagan Shawn, Journal of neurosurgical sciences . 2018,第6期

机译：克服抗抵抗障碍：针对念珠菌和念珠菌和念珠菌的药代动力学 - 药效学靶标体靶向分析rezafungin（CD101）
2. Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata [J] . Bader Justin C., Lakota Elizabeth A., Flanagan Shawn, Antimicrobial agents and chemotherapy. . 2018,第6期

机译：克服抗抵抗障碍：针对念珠菌和念珠菌和念珠菌的药代动力学 - 药效学靶标体靶向分析rezafungin（CD101）
3. Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant Candida albicans and Non-albicans Candida Species [J] . Jeffrey B. Locke, Amanda L. Almaguer, Joanna L. Donatelli, Infectious diseases in obstetrics and gynecology . 2018,第1期

机译：氟康唑敏感性和耐氟康唑白色念珠菌和非白色念珠菌种类的阴道模拟培养基中瑞沙芬净（CD101）的时空动力学
4. Ground-based results on the development of a microfluidics-based small satellite to examine the effects of microgravity on Candida albicans and Candida glabrata [C] . Jeffrey Osborne, Karen Morenz, Alejandro Duque, International Astronautical Congress . 2015

机译：基于地面的结果对基于微流体的小型卫星的发展，检查微匍匐对念珠菌和Candida Glabrata的影响
5. Novel Determinants That Influence Azole Susceptibility in Candida glabrata and Candida albicans [D] . Whaley, Sarah Garland. 2018

机译：影响含有唑米菌和念珠菌念珠菌和念珠菌蛋白敏感的新的决定因素
6. 1390. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Rezafungin (RZF) Dose Selection in Treatment of Candida [O] . Elizabeth A Lakota, Harish Ganesan, Shawn Flanagan, -1

机译：1390.药代动力学-药效学（PK-PD）目标分析支持瑞赞芬净（RZF）剂量选择治疗念珠菌
7. 1390. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Rezafungin (RZF) Dose Selection in Treatment of Candida [O] . Elizabeth A Lakota, Harish Ganesan, Shawn Flanagan, 2018

机译：1390.药代动力学药物动力学（PK-PD）靶率达到分析，以支持丹非州（RZF）剂量选择治疗念珠菌

Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata

著录项

引文网络

相似文献

相关主题

期刊订阅